Pure Global

2019-nCoV RBD Antibody Rapid Test - ARCSA Registration ebf5f7e554d1e1b7437f95f63aa1aec2

Access comprehensive regulatory information for 2019-nCoV RBD Antibody Rapid Test in the Ecuador medical device market through Pure Global AI's free database. This III medical device is registered under ARCSA ID ebf5f7e554d1e1b7437f95f63aa1aec2 and manufactured by GUANGZHOU WONDFO BIOTECH CO, LTD.. The device was registered on May 19, 2021.

This page provides complete registration details including product type (In Vitro Diagnostic), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.

Free Database
Powered by Pure Global AI
ARCSA Official Data
III
ebf5f7e554d1e1b7437f95f63aa1aec2
2019-nCoV RBD Antibody Rapid Test
ARCSA ID: ebf5f7e554d1e1b7437f95f63aa1aec2
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Device Classification
Risk Class
III
Product Type
In Vitro Diagnostic
Brand Name
Wondfo
Commercial Name
22-441-IVD Reagents/Testing Kits, Serology, Virus, Acute Respiratory Syndrome-Associated Coronavirus, COVID-19 IgG Antibodies
Registration Information
Analysis ID
ebf5f7e554d1e1b7437f95f63aa1aec2
Registration Date
May 19, 2021
Expiration Date
May 19, 2026
Product Use

THIS TEST IS DESIGNED TO HELP ASSESS THE ADAPTIVE HUMORAL IMMUNE RESPONSE TO 2019-NCOV

Manufacturer
City
LIZHISHAN
Country
CHINA
Address
NO. 8, LIZHISHAN AV., SCIENCE CITY, LUOGANG DISTRICT, 510663, GUANGZHOU, P.R. CHINA
Product Owner
Name
GUANGZHOU WONDFO BIOTECH CO, LTD.
Country
CHINA
Authorized Representative
Address
AV ELOY ALFARO N32-656 AND RUSSIA TROYA BUILDING SECOND FLOOR
Phone
6007782